パラセタモール市場規模、シェア、成長分析、タイプ別、製剤別、用途別、エンドユーザー別、流通チャネル別、地域別-2025-2032年産業予測

世界のパラセタモール市場規模は2023年に7億6,170万米ドルと評価され、2024年の7億9,679万米ドルから2032年には11億2,447万米ドルに成長し、予測期間（2025～2032年）のCAGRは4.4%で成長する見通しです。

一般用医薬品（OTC）の需要は、自己治療に対する意識の高まりや、軽度の病気は自分で治すという嗜好によって急増しています。この動向は、発熱、疼痛、頭痛のケースの増加によって強調され、その結果、しばしば必須医薬品に分類される手頃な価格のOTC製品の利用が増加しています。新興市場におけるヘルスケア・インフラの拡大も、アクセシビリティを高めています。とはいえ、厳しい承認プロセスがコスト増加や市場参入の遅れにつながるため、規制上のハードルや品質への懸念が業界利害関係者の課題となっています。誤用や依存などの問題は、消費者教育の充実と規制当局による監視の必要性を浮き彫りにしています。しかし、製剤の革新と製品ラインナップの拡大は成長機会をもたらし、企業はより安全で効果的なソリューションを開発するための研究開発に投資しており、市場の見通しは明るいです。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• ケーススタディ
• 規制情勢
• 顧客と購買基準の分析
• 特許分析

パラセタモール市場規模：タイプ別& CAGR（2025-2032年）

• 市場概要
• 動物用医薬品グレード
• アセトアミノフェングレード

パラセタモール市場規模：処方別& CAGR（2025-2032年）

• 市場概要
• 錠剤
• カプセル
• 液体懸濁液
• 粉
• その他

パラセタモール市場規模：用途別& CAGR（2025-2032年）

• 市場概要
• 疼痛管理
• 発熱管理
• 風邪とインフルエンザの緩和
• その他

パラセタモール市場規模：エンドユーザー別& CAGR（2025-2032年）

• 市場概要
• 病院
• クリニック
• ホームケア
• 外来手術センター

パラセタモール市場規模：流通チャネル別& CAGR（2025-2032年）

• 市場概要
• 小売薬局
• 病院薬局
• オンライン薬局
• スーパーマーケット/ハイパーマーケット

パラセタモール市場規模& CAGR（2025-2032年）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024年）

主要企業プロファイル

• Johnson & Johnson
• GSK Consumer Healthcare
• Sanofi
• Mallinckrodt Pharmaceuticals
• Granules India Limited
• Teva Pharmaceutical Industries Ltd.
• Sun Pharmaceutical Industries Ltd.
• Dr. Reddy's Laboratories
• Cipla Inc.
• Novartis
• Pfizer
• Abbott Laboratories
• Bayer AG
• Zydus Lifesciences
• Mylan（Viatris）
• Aurobindo Pharma
• Lupin Limited
• Torrent Pharmaceuticals
• Glenmark Pharmaceuticals
• Alkem Laboratories

結論と提言

Global Paracetamol Market size was valued at USD 761.7 Million in 2023 and is poised to grow from USD 796.79 Million in 2024 to USD 1124.47 Million by 2032, growing at a CAGR of 4.4% in the forecast period (2025-2032).

The demand for over-the-counter (OTC) drugs is surging, driven by a heightened awareness of self-treatment and a preference for managing minor ailments independently. This trend is underscored by a rise in cases of fever, pain, and headaches, resulting in increased utilization of affordable OTC products, which are often classified as essential medications. The expanding healthcare infrastructure in emerging markets also enhances accessibility. Nevertheless, regulatory hurdles and quality concerns challenge industry stakeholders, as stringent approval processes can increase costs and delay market entry. Issues such as misuse and dependency highlight the need for better consumer education and regulatory oversight. However, innovations in formulations and expanded product offerings present growth opportunities, with companies investing in research to develop safer, more effective solutions, indicating a positive outlook for the market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Paracetamol market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Paracetamol Market Segments Analysis

Global paracetamol market is segmented on the basis of type, formulation, application, end user, distribution channel and region. On the basis of type, the market is divided into acetaminophen grade and veterinary drug grade. On the basis of formulation, the market is divided into others, powder, liquid suspension, capsule and tablet. On the basis of application, the market is divided into other, cold and flu relief, fever management and pain management. By end user, the market has been segmented into hospitals, clinics, homecare, and ambulatory surgical centers. On the basis of distribution channel, the market has been segmented as Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, and Supermarkets/Hypermarkets. By geography, the market is studied across North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.

Driver of the Global Paracetamol Market

The global paracetamol market is significantly driven by the increasing prevalence of pain-related conditions such as arthritis, migraines, and back pain. According to the National Institutes of Health (NIH), approximately 20% of the adult population worldwide suffers from chronic pain, which has led governments and organizations, including McKesson Corporation and GlaxoSmithKline, to advocate for improved access to effective pain management solutions. As awareness and demand for pain relief options grow, paracetamol remains a key pharmaceutical product in addressing the challenges associated with these widespread ailments, ultimately fueling the expansion of the market.

Restraints in the Global Paracetamol Market

The global paracetamol market faces significant constraints due to the persistent problem of overdose. Major health organizations, including the FDA and EMA, have issued warnings regarding the risk of liver failure associated with excessive consumption. The CDC highlights paracetamol overdose as a leading cause of liver failure, prompting stricter regulations and enhanced safety protocols from industry leaders such as GlaxoSmithKline. These developments have led to increased scrutiny and precautionary measures, which may impact the availability and sales of paracetamol products in the market. Consequently, the industry must navigate these challenges to ensure consumer safety and regulatory compliance.

Market Trends of the Global Paracetamol Market

The Global Paracetamol market is witnessing a significant trend towards sustainable packaging solutions, driven by stringent regulations from governments in regions like the EU and North America aimed at promoting environmental responsibility within the pharmaceutical sector. This push for sustainability is compelling paracetamol manufacturers to shift towards eco-friendly packaging alternatives, with a growing emphasis on recyclable materials. The World Health Organization's commitment to minimizing pharmaceutical waste further reinforces this trend, prompting innovation among companies seeking to align with environmental standards while maintaining product integrity. As a result, the paracetamol market is evolving to meet both consumer demand for sustainability and regulatory compliance.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Customer & Buying Criteria Analysis
• Patent Analysis

Global Paracetamol Market Size by Type & CAGR (2025-2032)

• Market Overview
• Veterinary Drug Grade
• Acetaminophen Grade

Global Paracetamol Market Size by Formulation & CAGR (2025-2032)

• Market Overview
• Tablet
• Capsule
• Liquid Suspension
• Powder
• Others

Global Paracetamol Market Size by Application & CAGR (2025-2032)

• Market Overview
• Pain Management
• Fever Management
• Cold and Flu Relief
• Other

Global Paracetamol Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Clinics
• Homecare
• Ambulatory Surgical Centers

Global Paracetamol Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies
• Supermarkets/Hypermarkets

Global Paracetamol Market Size & CAGR (2025-2032)

• North America (Type, Formulation, Application, End User, Distribution Channel)
  • US
  • Canada
• Europe (Type, Formulation, Application, End User, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Formulation, Application, End User, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Formulation, Application, End User, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Formulation, Application, End User, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GSK Consumer Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mallinckrodt Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Granules India Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Reddy's Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cipla Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zydus Lifesciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan (Viatris)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aurobindo Pharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lupin Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Torrent Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Glenmark Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alkem Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations